Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy

American Journal of Ophthalmology

Volumn 133, Issue 2, 2002, Pages 242-248

  Brantley Jr , Milam A ^a   Worley, Lori ^a   Harbour, J William ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN BCL 2; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOGENETICS; ENUCLEATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR RECURRENCE; UVEA MELANOMA;

ADULT; AGED; BRACHYTHERAPY; COBALT RADIOISOTOPES; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA DAMAGE; DNA, NEOPLASM; EYE ENUCLEATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IODINE RADIOISOTOPES; MALE; MELANOMA; MIDDLE AGED; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UVEAL NEOPLASMS;

EID: 0036141475     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(01)01362-9     Document Type: Article

References (42)

1. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. III; Initial mortality findings. COMS Report No. 18
2. Long-term results of iodine 125 irradiation of uveal melanoma
3. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control
4. Choroidal melanoma treatment with iodine 125 brachytherapy
5. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy
6. Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy
7. Intraocular recurrence of uveal melanoma after proton beam irradiation
8. Metastatic risk for distinct patterns of post-irradiation local recurrence of posterior uveal melanoma
9. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma
10. Proliferation kinetics of x-irradiated mouse L cells studied with time-lapse photography. I. Experimental methods and data analysis
11. Biochemical modifier; hypoxic cell sensitizers
12. Molecular aspects of cellular responses to radiotherapy
13. Genetics of radiation resistance
14. Participation of p53 protein in the cellular response to DNA damage
15. p53 function and dysfunction
16. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent
17. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation
18. pRB plays an essential role in cell cycle arrest induced by DNA damage
19. Deregulation of the Rb and p53 pathways in uveal melanoma
20. DNA cell cycle studies in uveal melanoma
21. In vitro melanoma cell growth after pre-enucleation radiation therapy
22. Effect of pre-enucleation radiotherapy on the viability of human choroidal melanoma cells
23. Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study
24. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings
25. Analysis of radiation failure after uveal melanoma brachytherapy
26. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques
27. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma
28. Chromosome aberrations and radiation-induced cell death. II. Predicted and observed cell survival
29. X-ray-induced breakage and rejoining of human interphase chromosomes
30. Cytogenetic analysis of uveal melanoma. Consistent occurrence of monosomy 3 and trisomy 8q
31. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis
32. Cytogenetics of twelve cases of uveal melanoma and patterns of nonrandom anomalies and isochromosome formation
33. p53 oncoprotein overexpression in choroidal melanoma
34. p53 expression in uveal malignant melanomas
35. p53 gene and cell cycling in uveal melanoma
36. Increased expression and mutation of p53 in choroidal melanoma
37. Differential expression of the retinoblastoma gene family members in choroidal melanoma; Prognostic significance
38. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma
39. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma
40. The p53 pathway
41. A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity